Legal Representation
Attorney
Brian A. Tollefson
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 3, 2025 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
Feb 28, 2025 | 71AG | O | REGISTERED-SEC.71 ACCEPTED | Loading... |
Feb 28, 2025 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
Nov 15, 2024 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
Oct 25, 2024 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
Aug 21, 2024 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
Feb 24, 2024 | PR71 | O | POST REGISTRATION ACTION MAILED - SEC.71 | Loading... |
Feb 12, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Jun 5, 2023 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
Oct 24, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Oct 24, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 24, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Oct 24, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Oct 24, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 24, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 24, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 6, 2022 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
Apr 9, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Feb 22, 2018 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Oct 28, 2017 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Sep 14, 2017 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Sep 14, 2017 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Sep 6, 2017 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jun 6, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 21, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 21, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 17, 2017 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Mar 1, 2017 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Mar 1, 2017 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Mar 1, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 14, 2017 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 1, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 1, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 1, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 1, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 1, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 1, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 1, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 1, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 1, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jan 8, 2017 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jan 8, 2017 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jan 8, 2017 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Dec 22, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Dec 22, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 7, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 16, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 11, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 11, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jul 29, 2016 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and veterinary preparations, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for use in human [ and veterinary ] medicine; chemical preparations for pharmaceutical or medical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, syringes, infusion bags, vials and pharmaceutical preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for medical and pharmaceutical use for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; chemical preparations for pharmaceutical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical and veterinary purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use, namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes; biological reagents for medical use; medicinal products based on cells and genes, namely, somatic cells, genetically modified cells, viral vectors, nucleic acids and engineered tissues; products for somatic cell therapy, namely, adult stem cells, t-cells, b-cells, nk cells, dendritic cells, monocytes, macrophages, adipocytes, keratinocytes, erythrocytes, platelets, products for gene therapy, namely, genetically modified cells, viral vectors, nucleic acids; tissue engineered products, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace or restore a lost or impaired tissue or function; products for regenerative medicine, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace, restore or promote the repair, replacement or regeneration of a lost or impaired tissue or function; products for personalized medicine made of autologous cells or proteins or nucleid acids derived from individual genomic sequences; preparations made up of cells for medical or clinical use; preparations made up of nucleic acids, namely, nucleic acid sequences and chemical reagents for medical purposes; preparations made up of tissues, namely, biological tissue cultures for medical purposes; vaccines; recombinant proteins supplements; therapeutic kits consisting of therapeutic antibodies, buffers, and reagents for use in disease treatment and therapy
Class 010
[ Surgical apparatus and instruments for medical, dental and veterinary use; medical devices for the introduction of pharmaceutical preparations in the human body, in particular syringes and catheters; medical equipment, namely, centrifuges or other separation devices for the isolation of cell sub-populations from tissues and biopsies; surgical apparatus and instruments for medical and veterinary purpose; electrical medical instruments for use in electroporation of cells and tissues for gene transfer purposes, both in vivo and ex-vivo; electronic medical instruments for use in imaging for diagnostic purposes or for monitoring of vital signs of patients ]
Class 042
Services of laboratory analysis and industrial research in the medical and pharmaceutical fields; research and development in the pharmaceutical and biotechnology fields; research and development in the field of micro-organisms and cells; research and development in biochemistry; scientific research and development in biology; research and development in the field of diagnostic preparations; services of medical laboratories; Providing medical and scientific research information and data on developments in the medical and veterinary fields; scientific and technological services, namely, scientific research in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; consultancy to ensure compliance with quality standards and the design and validation of manufacturing processes in the scientific field and medical technology fields
Classification
International Classes
005
010
042